Conference Highlights AMCP
Identifying low-cost medication alternatives can be time-consuming and is often therefore not followed by clinicians. A group of pharmacists led by Nicole Allie, PharmD, CGP, at Atrius Health, Watertown, MA, instituted the Chart Flag Service, a program designed to alert prescribing providers, in real time, on appropriate, lowcost medication alternatives.
Enrollment in consumer-directed health plans (CDHPs) has evolved as a strategy to control healthcare costs and improve member satisfaction. According to the Mercer National Survey of Employer-Sponsored Health Plans, in 2010, 10% of employers offered their employees CDHPs; in 2011, that grew to 13%; and by June 8, 2012, 10% of employers offered CDHPs to their employees.
The use of high-deductible health plans (HDHPs) is a growing strategy by employers to control costs, who claim that they encourage member responsibility and reduce unnecessary care utilization. Opponents of HDHPs suggest that this may result in some members going without necessary care. Katrina Moore, PharmD, and colleagues at SelectHealth, Murray, UT, conducted a retrospective database analysis to compare medical and pharmacy costs, as well as clinical outcomes, between members in traditional health plans (N = 21,480) or in an HDHP (N = 971).
Knowledge of pharmacogenomics—a collection of genomic factors contributing to individual variability in response to drug therapy—enhances the ability to diagnose, prevent, and treat disease. Although understanding the correct application of pharmacogenomics may be essential to providing cost-effective care, barriers include the absence of provider knowledge and inappropriate reimbursement strategies. Angela Luong, PharmD, and colleagues at OPTUMInsight conducted a survey of pharmacists regarding their knowledge of genetic testing and utilization strategies.
The first known study to use real-world, nontrial data to evaluate the cost-effectiveness of first-line combination therapies for patients with advanced nonsquamous non–small-cell lung cancer (NSCLC) was conducted by Manan Shah, PharmD, PhD, and colleagues at Xcenda, Palm Harbor, FL. The therapies included were pemetrexed/ platinum (Pem/P) relative to carboplatin/paclitaxel plus bevacizumab (C/Pa + B).
Health plans seeking to improve their care management programs and reduce costs may wish to add a clinical pharmacist to their care management team, according to results of a study presented at the meeting by a group of pharmacy residents at OptumHealth Care Solutions Pharmaceutical Solutions Pharmacy Residency program at OptumHealth, in Golden Valley, MN.
Impact of Value-Based Insurance Design on Medication Utilization and Costs in a Large Retail Employer
Value-based insurance design (VBID) has been a driving force in lowering patients’ cost-sharing for evidence- based interventions that improve clinical outcomes. Yoona A. Kim, PharmD, and colleagues from the University of California San Francisco, the University of Texas at Austin, and Mercer Health & Benefits in San Francisco measured the impact of implementing a VBID program in a large retail employer on medication utilization and cost among employees taking medications for diabetes, asthma, coronary artery disease, or heart failure.
One successful strategy for employers and health plans wishing to cut spending on their employees or members with chronic diseases is to implement ways of encouraging strong medication adherence. In a poster presentation led by Patty M. Fong, PharmD, researchers from American Health Care plan, Rocklin, CA, have demonstrated that the degree of a patient’s medication adherence inversely correlates with the amount of total healthcare dollars spent on that patient.
Page 2 of 4
Results 11 - 20 of 40
Results 11 - 20 of 40